Expert Insights into Recent Updates for the Management of Lower-Risk MDS

home / investigator-perspectives / expert-insights-into-recent-updates-for-the-management-of-lower-risk-mds

Guillermo Garcia-Manero, MD, discusses recent advances presented at ASH 2023 in the treatment of myelodysplastic syndrome, highlighting both safety and efficacy of regimens in the frontline and second line setting.

EP. 1: Lower-Risk MDS: Current Treatment Landscape and Unmet Needs

Guillermo Garcia-Manero, MD

December 19th 2023

Dr Garica-Manero provides a brief overview of the current treatment paradigm for lower-risk MDS as well as discussing some unmet needs.

Watch

EP. 2: Approved and Emerging Regimens for Frontline and Second Line Lower-Risk MDS

Guillermo Garcia-Manero, MD

January 25th 2024

Guillermo Garcia-Manero, MD, highlights data updates presented at ASH 2023, outlining current and emerging therapies in frontline and second line lower-risk myelodysplastic syndrome (MDS).

Watch

EP. 3: Toxicity Management for Therapies in Lower-Risk MDS

Guillermo Garcia-Manero, MD

January 25th 2024

Dr. Garcia-Manero provides an overview of the toxicity profiles for therapies and mitigation strategies for patients with lower-risk MDS.

Watch

EP. 4: New Horizons in the Management of MDS

Guillermo Garcia-Manero, MD

January 25th 2024

Future perspective on the growing treatment landscape for patients with MDS.

Watch